Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal

NCT06982755 · Status: NOT_YET_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2025-05-21

No results posted yet for this study

Summary

The investigators designed this clinical study to evaluate the efficacy and safety of semi-standardized acupuncture and moxibustion combined with compound diclofenac sodium injection in the emergency department (ED) compared with acupuncture or compound diclofenac sodium injection alone.

Conditions

  • Acute Abdominal Pain
  • Acupuncture Therapy
  • Acupuncture
  • Opioids

Interventions

PROCEDURE

acupuncture

acupuncture at Zusanli (ST36); sample size: 44

DRUG

compound diclofenac sodium

intramuscular injection of compound diclofenac sodium injection; sample size: 44

COMBINATION_PRODUCT

acupuncture combined with compound diclofenac sodium

acupuncture at Zusanli (ST36) and intramuscular injection of compound diclofenac sodium injection; sample size: 44

COMBINATION_PRODUCT

placebo

superficial acupuncture at Zusanli (ST36) and intramuscular injection of normal saline; sample size: 44

Sponsors & Collaborators

  • The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Zhong Feng, Ph.D. · Hunan University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06982755 on ClinicalTrials.gov